Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about LPCN

Recent news which mentions LPCN

< Previous 1 2 Next >
Lipocine, Antares Ink Licensing Pact For Testosterone Replacement Therapy In US
Tickers ATRS LPCN
Tags Market News News Contracts
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Tickers ABIO ADVM AFIB AGRX
Tags CLLS NAUT LEGN
From Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Tickers ADVM AFIB AGTC AKYA
Tags ADVM MIRO PTPI
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Tickers ABEO ACER AFIB AGTC
Tags VYNE MBIO LIXT
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tickers ALT BNTX CODX EVLO
Tags Pre/Market Outlook BNTX ZIOP
From Benzinga
Lipocine Meets Resolution Regulatory Endpoint In Mid-Stage NASH Trial
Tickers LPCN
Tags Market News Long Ideas News
From Benzinga
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
Tickers AGEN ALRN AMRX ARGX
Tags VECT MRK Benzinga
From Benzinga
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Tickers ABCL ACET ACHL ADVM
Tags GMTX APTO MRSN
From Benzinga
22 Stocks Moving in Thursday's Pre-Market Session
Tickers AHPI AIG ARLO ATHE
Tags ARLO Benzinga Energy
From Benzinga
Lipocine Stock Jumps On Litigation Settlement With Clarus Therapeutics
Tickers LPCN
Tags News Market News General
From Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.